Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Dry Eye Syndrome market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Dry Eye Syndromemarket, defines the market attractiveness level of Dry Eye Syndrome market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Dry Eye Syndrome industry, describes the types of Dry Eye Syndrome market, the applications of major players and the market size, and deeply analyzes the current situation of the global Dry Eye Syndrome market and the development prospects and opportunities of Dry Eye Syndrome industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Dry Eye Syndrome market in Chapter 13.
By Player:
Otsuka Holdings Co Ltd
Allergan plc
Alimera Science
Nicox SA
Bausch + Lomb
Santen Pharmaceutical Co Ltd
Novartis AG
GlaxoSmithKline plc
Auven Therapeutics
Akorn Inc
By Type:
Anti-inflammatory Drugs
Lubricant Eye Drops
Autologous Serum Eye Drops
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Dry Eye Syndrome Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Dry Eye Syndrome Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Dry Eye Syndrome Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Dry Eye Syndrome Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Dry Eye Syndrome Market Analysis and Outlook to 2022
-
7.1 Global Dry Eye Syndrome Consumption (2017-2022)
-
7.2 United States Dry Eye Syndrome Consumption (2017-2022)
-
7.3 Europe Dry Eye Syndrome Consumption (2017-2022)
-
7.4 China Dry Eye Syndrome Consumption (2017-2022)
-
7.5 Japan Dry Eye Syndrome Consumption (2017-2022)
-
7.6 India Dry Eye Syndrome Consumption (2017-2022)
-
7.7 South Korea Dry Eye Syndrome Consumption (2017-2022)
8 Region and Country-wise Dry Eye Syndrome Market Analysis and Outlook to 2028
-
8.1 Global Dry Eye Syndrome Consumption Forecast (2022-2028)
-
8.2 United States Dry Eye Syndrome Consumption Forecast (2022-2028)
-
8.3 Europe Dry Eye Syndrome Consumption Forecast (2022-2028)
-
8.4 China Dry Eye Syndrome Consumption Forecast (2022-2028)
-
8.5 Japan Dry Eye Syndrome Consumption Forecast (2022-2028)
-
8.6 India Dry Eye Syndrome Consumption Forecast (2022-2028)
-
8.7 South Korea Dry Eye Syndrome Consumption Forecast (2022-2028)
9 Global Dry Eye Syndrome Market Outlook by Types and Applications to 2022
-
9.1 Global Dry Eye Syndrome Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lubricant Eye Drops Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Autologous Serum Eye Drops Consumption and Growth Rate (2017-2022)
-
9.2 Global Dry Eye Syndrome Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Dry Eye Syndrome Market Outlook by Types and Applications to 2028
-
10.1 Global Dry Eye Syndrome Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Lubricant Eye Drops Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Autologous Serum Eye Drops Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Dry Eye Syndrome Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Dry Eye Syndrome Import and Export Analysis (Top 5 Countries)
-
11.1 Global Dry Eye Syndrome Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Dry Eye Syndrome Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Dry Eye Syndrome Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Dry Eye Syndrome Market Competitive Analysis
-
14.1 Otsuka Holdings Co Ltd
-
14.1.1 Otsuka Holdings Co Ltd Company Details
-
14.1.2 Otsuka Holdings Co Ltd Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Otsuka Holdings Co Ltd Dry Eye Syndrome Product and Service
-
14.2 Allergan plc
-
14.2.1 Allergan plc Company Details
-
14.2.2 Allergan plc Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Allergan plc Dry Eye Syndrome Product and Service
-
14.3 Alimera Science
-
14.3.1 Alimera Science Company Details
-
14.3.2 Alimera Science Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Alimera Science Dry Eye Syndrome Product and Service
-
14.4 Nicox SA
-
14.4.1 Nicox SA Company Details
-
14.4.2 Nicox SA Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Nicox SA Dry Eye Syndrome Product and Service
-
14.5 Bausch + Lomb
-
14.5.1 Bausch + Lomb Company Details
-
14.5.2 Bausch + Lomb Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bausch + Lomb Dry Eye Syndrome Product and Service
-
14.6 Santen Pharmaceutical Co Ltd
-
14.6.1 Santen Pharmaceutical Co Ltd Company Details
-
14.6.2 Santen Pharmaceutical Co Ltd Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Santen Pharmaceutical Co Ltd Dry Eye Syndrome Product and Service
-
14.7 Novartis AG
-
14.7.1 Novartis AG Company Details
-
14.7.2 Novartis AG Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis AG Dry Eye Syndrome Product and Service
-
14.8 GlaxoSmithKline plc
-
14.8.1 GlaxoSmithKline plc Company Details
-
14.8.2 GlaxoSmithKline plc Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GlaxoSmithKline plc Dry Eye Syndrome Product and Service
-
14.9 Auven Therapeutics
-
14.9.1 Auven Therapeutics Company Details
-
14.9.2 Auven Therapeutics Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Auven Therapeutics Dry Eye Syndrome Product and Service
-
14.10 Akorn Inc
-
14.10.1 Akorn Inc Company Details
-
14.10.2 Akorn Inc Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Akorn Inc Dry Eye Syndrome Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Dry Eye Syndrome
-
Figure Dry Eye Syndrome Picture
-
Table Global Dry Eye Syndrome Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dry Eye Syndrome Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dry Eye Syndrome Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Dry Eye Syndrome Consumption by Country (2017-2022)
-
Figure United States Dry Eye Syndrome Consumption and Growth Rate (2017-2022)
-
Table Europe Dry Eye Syndrome Consumption and Growth Rate (2017-2022)
-
Figure China Dry Eye Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Japan Dry Eye Syndrome Consumption and Growth Rate (2017-2022)
-
Figure India Dry Eye Syndrome Consumption and Growth Rate (2017-2022)
-
Figure South Korea Dry Eye Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Dry Eye Syndrome Consumption Forecast by Country (2022-2028)
-
Figure United States Dry Eye Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Dry Eye Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Dry Eye Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Dry Eye Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Dry Eye Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Dry Eye Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Lubricant Eye Drops Consumption and Growth Rate (2017-2022)
-
Figure Global Autologous Serum Eye Drops Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lubricant Eye Drops Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autologous Serum Eye Drops Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Dry Eye Syndrome Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Dry Eye Syndrome Export by Region (Top 5 Countries) (2017-2028)
-
Table Otsuka Holdings Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Otsuka Holdings Co Ltd Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Holdings Co Ltd Dry Eye Syndrome Product and Service
-
Table Allergan plc (Foundation Year, Company Profile and etc.)
-
Table Allergan plc Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan plc Dry Eye Syndrome Product and Service
-
Table Alimera Science (Foundation Year, Company Profile and etc.)
-
Table Alimera Science Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alimera Science Dry Eye Syndrome Product and Service
-
Table Nicox SA (Foundation Year, Company Profile and etc.)
-
Table Nicox SA Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nicox SA Dry Eye Syndrome Product and Service
-
Table Bausch + Lomb (Foundation Year, Company Profile and etc.)
-
Table Bausch + Lomb Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bausch + Lomb Dry Eye Syndrome Product and Service
-
Table Santen Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Santen Pharmaceutical Co Ltd Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Santen Pharmaceutical Co Ltd Dry Eye Syndrome Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Dry Eye Syndrome Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Dry Eye Syndrome Product and Service
-
Table Auven Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Auven Therapeutics Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Auven Therapeutics Dry Eye Syndrome Product and Service
-
Table Akorn Inc (Foundation Year, Company Profile and etc.)
-
Table Akorn Inc Dry Eye Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akorn Inc Dry Eye Syndrome Product and Service
-
